Nasopharyngeal Carcinoma NPC
Conditions
Interventions
intervention group:Patients in the intervention group were given routine care and psychological care for synchronized radiotherapy, which mainly consisted of introduction of knowledge related to synch
the researchers will upload disease-related content and other content in the app's science circle, which is convenient for patients to view and learn, and promotes patients' knowledge and understandin
the research team urged patients to complete the exercise through the online app Through the online app, the research team urges patients to complete the time and frequency of the exercises, and encou
control group:Patients were given synchronized radiotherapy routine care and psychological care, which mainly consisted of introduction of knowledge related to synchronize
Sponsors
Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)Age 18~65 years old; (2) Nasopharyngeal cancer was diagnosed by Nasopharyngeal Carcinoma , pathology, EB virus shell antigen, antibody and CT. (3) The treatment plan was simultaneous radiotherapy and chemotherapy. The radiotherapy program was intensity-modulated radiotherapy (IMRT), with a dose of (1.8-2.2) Gy/times for 31-33 times. (4) A score of >= 27 on the Brief Intelligent Mental State Examination (MMSE) scale; (5) Ability to operate a smartphone, with daily internet access on the phone, and use the phone for >= 1 hour per day; (6) No language barrier and good communication; ability to read, write and speak Chinese. (7) Informed consent and voluntary acceptance to cooperate with the implementation of this study.
Exclusion criteria
Exclusion criteria: (1) Expected survival <6 months; (2) Are participating or have previously participated in a pilot study of orthostatic intervention; (3) Combined cardiovascular, cerebrovascular, liver and renal dysfunction severe or other types of malignant tumors; (4) With severe malnutrition before radiotherapy, i.e., serum albumin < 30 g/L or body mass index (BMI, kg/m^2) < 18. 5; (5) Those suffering from mental illness or disorders of consciousness or communication; (6) Taking any psychotropic medications during the study period, such as antidepressants, antipsychotics, mood stabilizers, narcotics, and benzodiazepines, as well as any prescription for insomnia or other antidepressants;
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| sense of shame;mindfulness level;Quality of life;psychological distress; | — |
Primary
| Measure | Time frame |
|---|---|
| post-traumatic growth; | — |
Countries
China
Contacts
Public ContactGaoYun
Guangzhou Medical University
Outcome results
None listed